当前位置:首页 - 行情中心 - 晨光生物(300138) - 财务分析 - 现金流量表

晨光生物

(300138)

  

流通市值:41.70亿  总市值:49.76亿
流通股本:4.46亿   总股本:5.33亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,878,730,359.987,105,883,164.864,990,270,391.893,584,900,786.67
收到的税费返还61,114,695.46114,840,153.73100,392,231.8597,482,132.89
收到其他与经营活动有关的现金27,453,205.89200,850,679.41131,790,238.9597,119,767.95
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,967,298,261.337,421,573,9985,222,452,862.693,779,502,687.51
购买商品、接受劳务支付的现金1,599,602,962.867,485,391,728.33,806,653,510.112,808,244,339.9
支付给职工以及为职工支付的现金68,676,421.15264,143,586.66199,373,406.07129,346,163.21
支付的各项税费49,034,304.37124,288,931.9792,493,638.5878,586,859.47
支付其他与经营活动有关的现金52,553,049.1136,218,923.76128,293,702.4380,760,860.98
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,769,866,737.488,010,043,170.694,226,814,257.193,096,938,223.56
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额197,431,523.85-588,469,172.69995,638,605.5682,564,463.95
二、投资活动产生的现金流量:
收回投资收到的现金648,538,819118,863,442.35966,617,738.65653,543,783.55
取得投资收益收到的现金15,080,727.3577,561,964.6563,076,034.1249,556,372.13
处置固定资产、无形资产和其他长期资产收回的现金净额-283,823.87332,711.23314,525.87
投资活动现金流入的平衡项目0000
投资活动现金流入小计663,619,546.35196,709,230.871,030,026,484703,414,681.55
购建固定资产、无形资产和其他长期资产支付的现金34,050,563.38189,199,325.79142,361,947.4690,682,059.32
投资支付的现金157,434,766.6455,777,428.21905,984,439.5495,547,444.9
投资活动现金流出的平衡项目0000
投资活动现金流出小计191,485,329.98644,976,7541,048,346,386.96586,229,504.22
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额472,134,216.37-448,267,523.13-18,319,902.96117,185,177.33
三、筹资活动产生的现金流量:
取得借款收到的现金1,453,585,020.24,677,667,378.72,588,703,439.91,526,983,439.9
收到其他与筹资活动有关的现金1,970,000498,939,000198,000,00048,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,455,555,020.25,176,606,378.72,786,703,439.91,574,983,439.9
偿还债务支付的现金812,000,0003,379,969,305.562,128,698,888.891,249,498,888.89
分配股利、利润或偿付利息支付的现金29,373,479.56181,414,538.38147,865,357.99127,089,665.13
支付其他与筹资活动有关的现金148,021,065.24318,406,134220,980,000220,000,000
筹资活动现金流出平衡项目0000
筹资活动现金流出小计989,394,544.83,879,789,977.942,497,544,246.881,596,588,554.02
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额466,160,475.41,296,816,400.76289,159,193.02-21,605,114.12
四、汇率变动对现金及现金等价物的影响-2,405,269.04-6,050,321.18-5,308,661.6534,315.2
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额1,133,320,946.58254,029,383.761,261,169,233.91778,178,842.36
加:期初现金及现金等价物余额1,085,264,962.72831,235,578.96831,235,578.96831,235,578.96
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,218,585,909.31,085,264,962.722,092,404,812.871,609,414,421.32
补充资料:
净利润-494,173,306.76-314,892,436.62
资产减值准备--4,056,267.83--12,907,442.35
固定资产和投资性房地产折旧-144,428,199.51-61,349,333.26
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-144,428,199.51-61,349,333.26
无形资产摊销-8,115,719.32-4,190,506.41
长期待摊费用摊销-200,000.04-100,000.02
处置固定资产、无形资产和其他长期资产的损失-632,753-1,551.18
固定资产报废损失-1,102,030.14-858,664.76
公允价值变动损失--5,363,332.98--6,583,420.53
财务费用-70,091,151.09-42,128,967.66
投资损失--68,655,795.66--47,643,119.39
递延所得税--8,603,640.79-6,500,351.57
其中:递延所得税资产减少--8,601,758.19-5,981,402.53
递延所得税负债增加--1,882.6-518,949.04
存货的减少--1,145,375,047.35-319,571,994.14
经营性应收项目的减少-135,235,688.81-285,339,718.28
经营性应付项目的增加--211,804,447.51--285,918,649.67
现金的期末余额-875,264,962.72-1,319,414,421.32
减:现金的期初余额-601,235,578.96-601,235,578.96
加:现金等价物的期末余额-210,000,000-290,000,000
减:现金等价物的期初余额-230,000,000-230,000,000
公告日期2024-04-252024-04-182023-10-242023-08-14
审计意见(境内)标准无保留意见
TOP↑